ELAVL1 and neoplasm: Strategies such as suppressing HuR gene expression, disrupting HuR-target mRNA interactions, employing gene interference technologies, and combining HuR inhibition with radiotherapy/chemotherapy have shown efficacy in inhibiting tumor cell proliferation, metastasis, and drug resistance.